ExodusPoint Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-18,676
Closed -$133K 2624
2022
Q1
$133K Sell
18,676
-20,682
-53% -$171K ﹤0.01% 1973
2021
Q4
$716K Sell
39,358
-9,974
-20% -$215K 0.01% 1240
2021
Q3
$965K Buy
+49,332
New +$1.88M 0.01% 1045

Other funds holding CELL

ExodusPoint Capital Management's CELL Position: Q2 2022 in Review

ExodusPoint Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 18,676 shares — an estimated $133K sold.

ExodusPoint Capital Management first reported a position in CELL in Q3 2021 and held it in 3 quarters. The position peaked at $965K in Q3 2021. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.

  • ExodusPoint Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 18,676 PhenomeX Inc. Common Stock shares in Q2 2022, an estimated $133K.
  • ExodusPoint Capital Management first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • ExodusPoint Capital Management's PhenomeX Inc. Common Stock position peaked at $965K in Q3 2021.
  • 123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.